These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23410990)

  • 1. Influence of membrane structure on the preparation of colloidal lipid dispersions by premix membrane emulsification.
    Joseph S; Bunjes H
    Int J Pharm; 2013 Mar; 446(1-2):59-62. PubMed ID: 23410990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Shirasu Porous Glass (SPG) membrane emulsification for the preparation of colloidal lipid drug carrier dispersions.
    Joseph S; Bunjes H
    Eur J Pharm Biopharm; 2014 May; 87(1):178-86. PubMed ID: 24333666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of nanoemulsions and solid lipid nanoparticles by premix membrane emulsification.
    Joseph S; Bunjes H
    J Pharm Sci; 2012 Jul; 101(7):2479-89. PubMed ID: 22527807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of lipid nanoemulsions by premix membrane emulsification with disposable materials.
    Gehrmann S; Bunjes H
    Int J Pharm; 2016 Sep; 511(2):741-4. PubMed ID: 27477104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of membrane material on the production of colloidal emulsions by premix membrane emulsification.
    Gehrmann S; Bunjes H
    Eur J Pharm Biopharm; 2018 May; 126():140-148. PubMed ID: 27870930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Nanoemulsions by Premix Membrane Emulsification: Which Parameters Have a Significant Influence on the Resulting Particle Size?
    Gehrmann S; Bunjes H
    J Pharm Sci; 2017 Aug; 106(8):2068-2076. PubMed ID: 28479362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of solid lipid nanoparticles using a membrane contactor.
    Charcosset C; El-Harati A; Fessi H
    J Control Release; 2005 Nov; 108(1):112-20. PubMed ID: 16169111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of monodisperse polymer nanoparticles by membrane emulsification using ordered anodic porous alumina.
    Yanagishita T; Fujimura R; Nishio K; Masuda H
    Langmuir; 2010 Feb; 26(3):1516-9. PubMed ID: 20000338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
    Rosenblatt KM; Bunjes H
    Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication strategy for amphiphilic microcapsules with narrow size distribution by premix membrane emulsification.
    Wei Y; Wang Y; Wang L; Hao D; Ma G
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):399-408. PubMed ID: 21683559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premix Membrane Emulsification: Preparation and Stability of Medium-Chain Triglyceride Emulsions with Droplet Sizes below 100 nm.
    El-Hawari L; Bunjes H
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural investigations on lipid nanoparticles containing high amounts of lecithin.
    Schubert MA; Harms M; Müller-Goymann CC
    Eur J Pharm Sci; 2006 Feb; 27(2-3):226-36. PubMed ID: 16298113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles.
    Kupetz E; Bunjes H
    J Control Release; 2014 Sep; 189():54-64. PubMed ID: 24933601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
    Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro and nano polycaprolactone particles preparation by pulsed back-and-forward cross-flow batch membrane emulsification for parenteral administration.
    Imbrogno A; Piacentini E; Drioli E; Giorno L
    Int J Pharm; 2014 Dec; 477(1-2):344-50. PubMed ID: 25445520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process.
    Fangueiro JF; Andreani T; Egea MA; Garcia ML; Souto SB; Souto EB
    Colloids Surf B Biointerfaces; 2012 Dec; 100():84-9. PubMed ID: 22766285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control over Particle Size Distribution by Autoclaving Poloxamer-Stabilized Trimyristin Nanodispersions.
    Göke K; Roese E; Arnold A; Kuntsche J; Bunjes H
    Mol Pharm; 2016 Sep; 13(9):3187-95. PubMed ID: 27463039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.
    Wang LY; Ma GH; Su ZG
    J Control Release; 2005 Aug; 106(1-2):62-75. PubMed ID: 15922472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
    Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles as drug delivery systems.
    Manjunath K; Reddy JS; Venkateswarlu V
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.